Anaphore, Inc. Lands $13,000,000 Series A Funding

  • Feed Type
  • Date
    5/14/2009
  • Company Name
    Anaphore, Inc.
  • Mailing Address
    Undisclosed San Diego, CA 92120
  • Company Description
    Anaphore was created through the acquisition of Borean Pharma ApS, a Danish biotechnology company with both a product portfolio and technology platforms for creating improved protein therapeutics. The Danish firm spent six years establishing the technologies and therapeutic pipeline that provides the strong foundation for Anaphore. Anaphore offers technology collaborations in all therapeutic areas. Anaphore’s internal product development opportunities will initially focus on immune-based diseases.
  • Website
    http://www.anaphoreinc.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $13,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    Merck Serono Ventures
  • Venture Investor
    Aravis Ventures

Trending on Xconomy